Latest Remuneration News

Page 17 of 120
Green & Gold Minerals posted a $886,828 loss for FY2026 amid a transformative year marked by its ASX listing and expansion into base metals exploration with the Herberton acquisition.
Maxwell Dee
Maxwell Dee
27 Aug 2026
NEXTDC has swung to a statutory profit of $82.1 million in FY26, driven by a record 202% jump in contracted utilisation and a strategic shift in lease accounting that added a $128.8 million fair value gain. The company’s $3.4 billion capital expenditure underscores its aggressive expansion, including the opening of its first international data centre in Kuala Lumpur.
Sophie Babbage
Sophie Babbage
27 Aug 2026
Dubber Corporation Limited (ASX:DUB) posted a 17% revenue drop in FY26 to $35.1 million, mainly due to a major contract loss in Europe, but narrowed its net loss by 78% excluding impairments and achieved cash flow breakeven in H2.
Sophie Babbage
Sophie Babbage
27 Aug 2026
Beonic Limited grew revenue by 5.2% to $23.3 million in FY26, halving its loss and achieving positive operating cash flow, underpinned by a landmark Moroccan airport contract and product innovation.
Sophie Babbage
Sophie Babbage
27 Aug 2026
Actinogen Medical reported a $15.38 million loss for FY2026 while progressing its lead Alzheimer's drug Xanamem toward pivotal trial results expected this November. The company secured regulatory alignment and strengthened its cash position to fund operations through mid-2027.
Ada Torres
Ada Torres
27 Aug 2026
Acorn Capital Investment Fund Limited posted a 35% drop in profit after tax to $6.25 million for FY2026, while its portfolio outperformed the Small Ords benchmark with a 9.8% return. The company declared fully franked dividends of 3.5 cents per share.
Claire Turing
Claire Turing
27 Aug 2026
Industrial Minerals Ltd has finalised its takeover of Galleon Metals, adding a 205km² gold exploration portfolio in WA’s Eastern Goldfields. The company also announced key board appointments, including a new Managing Director with direct Laverton expertise.
Maxwell Dee
Maxwell Dee
27 Aug 2026
Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.
Ada Torres
Ada Torres
27 Aug 2026
Winton Land’s governance is under strain after independent directors Steven Joyce and Guy Fergusson resigned citing conflicts with the majority shareholder. The board must urgently appoint new independent directors to maintain NZX compliance and avoid potential trading suspension.
Eva Park
Eva Park
27 Aug 2026
SenSen Networks reported a 16.7% rise in annualised recurring revenue to $11.7 million and a 23.6% EBITDA increase to $2.0 million in FY26, while expanding its SenDISA platform into environmental enforcement with EPA Victoria.
Sophie Babbage
Sophie Babbage
27 Aug 2026
Clarity Pharmaceuticals reported a 67% increase in net loss to $107.2 million for FY26, driven by higher R&D spending, while advancing multiple Phase III trials and expanding manufacturing capacity ahead of commercialisation.
Ada Torres
Ada Torres
27 Aug 2026
Aeris Resources delivered a standout FY26 with revenues up 22% and profit after tax surging 295%, buoyed by operational gains and a strategic acquisition of Peel Mining.
Maxwell Dee
Maxwell Dee
27 Aug 2026

Browse the archive

Full archive